Cargando…

Parkinson’s Disease-Related Brain Metabolic Pattern Is Expressed in Schizophrenia Patients during Neuroleptic Drug-Induced Parkinsonism

Drug-induced parkinsonism (DIP) is a frequent parkinsonian syndrome that appears as a result of pharmacotherapy for the management of psychosis. It could substantially hamper treatment and therefore its diagnosis has a direct influence on treatment effectiveness. Although of such high importance, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kotomin, Ivan, Korotkov, Alexander, Solnyshkina, Irina, Didur, Mikhail, Cherednichenko, Denis, Kireev, Maxim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818349/ https://www.ncbi.nlm.nih.gov/pubmed/36611366 http://dx.doi.org/10.3390/diagnostics13010074

Ejemplares similares

Providing Evidence for the Null Hypothesis in Functional Magnetic Resonance Imaging Using Group-Level Bayesian Inference
por: Masharipov, Ruslan, et al.
Publicado: (2021)

Social Interaction With an Anonymous Opponent Requires Increased Involvement of the Theory of Mind Neural System: An fMRI Study
por: Zheltyakova, Maya, et al.
Publicado: (2022)

Impaired Non-Selective Response Inhibition in Obsessive-Compulsive Disorder
por: Masharipov, Ruslan, et al.
Publicado: (2023)

Parkinson disease and Neuroleptic withdrawal
por: Jambunathan, Stephen, et al.
Publicado: (2010)

Neuroleptic‐induced Parkinsonism: Clinicopathological study
por: Shuaib, Umar A., et al.
Publicado: (2015)

The Interaction Between Caudate Nucleus and Regions Within the Theory of Mind Network as a Neural Basis for Social Intelligence
por: Votinov, Mikhail, et al.
Publicado: (2021)

Re-emergent Tongue Tremor in Neuroleptic-induced Parkinsonism
por: Prasad, Shweta, et al.
Publicado: (2019)

Suppression of non-selected solutions as a possible brain mechanism for ambiguity resolution in the word fragment task completion task
por: Kireev, Maxim, et al.
Publicado: (2022)

Brain metabolic alterations herald falls in patients with Parkinson’s disease
por: Isaias, Ioannis U., et al.
Publicado: (2020)

Spontaneous parkinsonisms and striatal impairment in neuroleptic free youth at ultrahigh risk for psychosis
por: Dean, Derek J, et al.
Publicado: (2015)

Symptomatic Characteristics of Parkinson's Disease Induced by Neuroleptic Drugs, Based on a Functional Neuroimaging Diagnosis
por: Tachibana, Kei, et al.
Publicado: (2020)

NEUROLEPTIC MALIGNANT SYNDROME - A CASE REPORT
por: De souza, Joaquim Victor, et al.
Publicado: (1986)

Electroconvulsive Therapy for Parkinson’s Disease with Depression and Neuroleptic Malignant Syndrome: A Case Report
por: Mori, Yuhei, et al.
Publicado: (2021)

NEUROLEPTIC-INDUCED LARYNGEAL DYSTONIA
por: Andrade, Chittaranjan, et al.
Publicado: (1988)

Missing Dosages and Neuroleptic Usage May Prolong Length of Stay in Hospitalized Parkinson's Disease Patients
por: Martinez-Ramirez, Daniel, et al.
Publicado: (2015)

metabolic profiling of Parkinson's disease and mild cognitive impairment
por: Burté, Florence, et al.
Publicado: (2017)

NEUROLEPTIC - INDUCED ACUTE DYSTONIA IN SCHIZOPHRENIA AND MANIA1
por: Pandey, Ravi S., et al.
Publicado: (1992)

Altered functional connectivity links in neuroleptic-naïve and neuroleptic-treated patients with schizophrenia, and their relation to symptoms including volition
por: Pu, Weidan, et al.
Publicado: (2014)

Risk of Neuroleptic Malignant Syndrome with Vesicular Monoamine Transporter Inhibitors
por: Caroff, Stanley N.
Publicado: (2020)

Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease()
por: Dunn, Laura, et al.
Publicado: (2014)

Persistent Racial Disparities in Deep Brain Stimulation for Parkinson's Disease
por: Cramer, Samuel W., et al.
Publicado: (2022)

Movement disorders in neuroleptic-naïve patients with schizophrenia spectrum disorders
por: Ayehu, Moges, et al.
Publicado: (2014)

The avascular zone and neuronal remodeling of the fovea in Parkinson disease
por: Miri, Shahnaz, et al.
Publicado: (2015)

The reconfiguration pattern of individual brain metabolic connectome for Parkinson's disease identification
por: Li, Weikai, et al.
Publicado: (2023)

Cure or Curse? Ambivalent Attitudes Towards Neuroleptic Medication in Schizophrenia and Non-Schizophrenia Patients
por: Moritz, Steffen, et al.
Publicado: (2009)

Neuroleptic-induced movement disorders in a naturalistic schizophrenia population: diagnostic value of actometric movement patterns
por: Janno, Sven, et al.
Publicado: (2008)

Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
por: Towns, Clodagh, et al.
Publicado: (2023)

Immunosuppressants and risk of Parkinson disease
por: Racette, Brad A., et al.
Publicado: (2018)

Dopamine Transporter Single-Photon Emission Computerized Tomography Supports Diagnosis of Akinetic Crisis of Parkinsonism and of Neuroleptic Malignant Syndrome
por: Martino, G., et al.
Publicado: (2015)

Analysis of Parkinson's disease brain–derived DNA for alpha-synuclein coding somatic mutations
por: Proukakis, Christos, et al.
Publicado: (2014)

Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2)
por: Lange, Lara M., et al.
Publicado: (2023)

Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam
por: Yacoub, Adeeb, et al.
Publicado: (2006)

Neuronal Dynamics of Pain in Parkinson’s Disease
por: Kinugawa, Kaoru, et al.
Publicado: (2021)

Gender Differences in the Prevalence of Parkinson's Disease
por: Zirra, Alexandra, et al.
Publicado: (2022)

Neuroleptic malignant-like syndrome with a slight elevation of creatine-kinase levels and respiratory failure in a patient with Parkinson’s disease
por: Wei, Li, et al.
Publicado: (2014)

Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts
por: Meles, Sanne K., et al.
Publicado: (2019)

SERUM PROLACTIN LEVELS IN SCHIZOPHRENIA: EFFECTS OF NEUROLEPTIC MEDICATION - A PRELIMINARY STUDY
por: Kuruvilla, K., et al.
Publicado: (1986)

Homeostatic Imbalance of Purine Catabolism in First-Episode Neuroleptic-Naïve Patients with Schizophrenia
por: Yao, Jeffrey K., et al.
Publicado: (2010)

Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder
por: Moncrieff, Joanna, et al.
Publicado: (2020)

Relationships between dorsolateral prefrontal cortex metabolic change and cognitive impairment in first-episode neuroleptic-naive schizophrenia patients
por: Huang, Man-Li, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sulrcqji1lu1nsfi3k1tph9vlq